← Eichor
Study identifier: NCT07072624 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Early Post-Traumatic Seizures Prevention Trial (E-PTS Trial)

Condition: Seizures · Traumatic Brain Injuries · Traumatic Brain Injury (TBI) Patients  ·  Sponsor: All India Institute of Medical Sciences, Jodhpur

PhasePhase 4
Planned participants1260
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

Rationale/gaps in existing knowledge: The prophylaxis for post-traumatic seizures (PTS) remains controversial due to a lack of class I evidence. Investigators plan to conduct a high-quality, prospective, multicentric, randomized study regarding seizure prophylaxis in traumatic brain injury (TBI) with phenytoin, levetiracetam, and the placebo in three respective treatment groups, along with the effect of drug polymorphism on seizure occurrence. Novelty: Literature is scarce regarding the ideal management of early PTS in traumatic brain injury (TBI), a major public health problem. Further, no study has evaluated the effect of genetic polymorphism on seizure occurrence in traumatic brain injury. This Multicentric study will be the first of its kind, not only in India but also globally. Objectives: To evaluate the seizure incidence \& efficacy of the respective anti-epileptic drug in each treatment arm. Assessment of clinical \& functional outcomes, safety profile, and cost-effectiveness in each group. Effect of genetic polymorphisms on seizure incidence among study participants Methods: A Multicentric prospective randomized placebo-controlled double-blinded clinical trial is planned. After satisfying eligibility criteria and informed consent, TBI patients will be randomly allocated into three arms 'phenytoin arm', 'levetiracetam arm', and 'placebo'. Drug polymorphism will be analyzed in all the patients using quantitative real-time PCR. Expected outcome: This study will provi…

This description comes directly from the study's public registry record.

Talk to the study team

Dr Jaskaran Singh Gosal Associate Professor, MCh Neurosurgery  ·  91 6283475891  ·  jhsgosal_87@hotmail.com

Dr Shoban Babu Varthya Associate Professor, MD Pharmacology  ·  91 8437726777  ·  drshobanpgimer@gmail.com

Always discuss trial participation with your own doctor first.

Locations (3)

Postgraduate Institute of Medical Education & ResearchChandigarh, Punjab, IndiaRecruiting
AIIMS JodhpurJodhpur, Rajasthan, IndiaRecruiting
Sanjay Gandhi Postgraduate Institute of Medical SciencesLucknow, Uttar Pradesh, IndiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07072624